Comparison of Anesthetic Efficacy OF 2% Lidocaine Inferior Alveolar Nerve (IANB) Block Versus Primary Buccal Infilteration With 4% Articaine in Symptomatic Irreversible Pulpitis(SIP) IN Mandibular First Molars

Recruiting N/A Interventional Study
Anesthetic Efficacy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 55
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
330 (estimated)
Sponsor
Armed Forces Institute of Dentistry, Pakistan · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This randomized controlled trial aims to compare the anesthetic efficacy of 2% lignocaine administered through an inferior alveolar nerve block (IANB) in one group of participants with 4% articaine delivered via primary buccal infiltration in other group in patients with symptomatic irreversible pulpitis in mandibular first molars.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Systemically healthy patients classified as ASA I, aged 18-55 years. * Permanent mandibular first molar tooth requiring endodontic therapy. * Diagnosed with symptomatic irreversible pulpitis without swelling or sinus. * Normal periapical radiographic appearance (no evidence of…
Contacts

Dr. Sadia Shehzadi Dr. Sadia Shehzadi, BDS,FCPS(PG3)

03342073051

sadiashehzadi321@gmail.com

CONTACT